Logo image of IVVD

INVIVYD INC (IVVD) Stock Overview

NASDAQ:IVVD - US00534A1025 - Common Stock

1.14 USD
+0.14 (+14.29%)
Last: 9/5/2025, 8:23:22 PM
1.13 USD
-0.01 (-0.88%)
Pre-Market: 9/8/2025, 4:43:15 AM

IVVD Key Statistics, Chart & Performance

Key Statistics
52 Week High2.74
52 Week Low0.35
Market Cap238.69M
Shares209.38M
Float169.18M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.97
PEN/A
Fwd PE2.15
Earnings (Next)11-12 2025-11-12/amc
IPO08-06 2021-08-06
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


IVVD short term performance overview.The bars show the price performance of IVVD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

IVVD long term performance overview.The bars show the price performance of IVVD in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 -60

The current stock price of IVVD is 1.14 USD. In the past month the price increased by 51.27%. In the past year, price increased by 40.05%.

INVIVYD INC / IVVD Daily stock chart

IVVD Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.07 375.50B
AMGN AMGEN INC 13.01 152.70B
GILD GILEAD SCIENCES INC 14.86 142.76B
VRTX VERTEX PHARMACEUTICALS INC 23.38 101.56B
REGN REGENERON PHARMACEUTICALS 12.56 60.77B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.25B
ARGX ARGENX SE - ADR 80.99 45.95B
ONC BEONE MEDICINES LTD-ADR 5.99 40.63B
INSM INSMED INC N/A 30.67B
BNTX BIONTECH SE-ADR N/A 27.03B
NTRA NATERA INC N/A 23.06B
BIIB BIOGEN INC 8.79 20.62B

About IVVD

Company Profile

IVVD logo image Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is headquartered in Waltham, Massachusetts and currently employs 99 full-time employees. The company went IPO on 2021-08-06. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The firm delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The firm also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.

Company Info

INVIVYD INC

1601 Trapelo Road, Suite 178

Waltham MASSACHUSETTS US

Employees: 99

IVVD Company Website

IVVD Investor Relations

Phone: 17818190080

INVIVYD INC / IVVD FAQ

What is the stock price of INVIVYD INC today?

The current stock price of IVVD is 1.14 USD. The price increased by 14.29% in the last trading session.


What is the ticker symbol for INVIVYD INC stock?

The exchange symbol of INVIVYD INC is IVVD and it is listed on the Nasdaq exchange.


On which exchange is IVVD stock listed?

IVVD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INVIVYD INC stock?

8 analysts have analysed IVVD and the average price target is 3.06 USD. This implies a price increase of 168.42% is expected in the next year compared to the current price of 1.14. Check the INVIVYD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INVIVYD INC worth?

INVIVYD INC (IVVD) has a market capitalization of 238.69M USD. This makes IVVD a Micro Cap stock.


How many employees does INVIVYD INC have?

INVIVYD INC (IVVD) currently has 99 employees.


What are the support and resistance levels for INVIVYD INC (IVVD) stock?

INVIVYD INC (IVVD) has a support level at 0.53. Check the full technical report for a detailed analysis of IVVD support and resistance levels.


Is INVIVYD INC (IVVD) expected to grow?

The Revenue of INVIVYD INC (IVVD) is expected to grow by 380.75% in the next year. Check the estimates tab for more information on the IVVD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INVIVYD INC (IVVD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INVIVYD INC (IVVD) stock pay dividends?

IVVD does not pay a dividend.


When does INVIVYD INC (IVVD) report earnings?

INVIVYD INC (IVVD) will report earnings on 2025-11-12, after the market close.


What is the Price/Earnings (PE) ratio of INVIVYD INC (IVVD)?

INVIVYD INC (IVVD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.97).


What is the Short Interest ratio of INVIVYD INC (IVVD) stock?

The outstanding short interest for INVIVYD INC (IVVD) is 1.8% of its float. Check the ownership tab for more information on the IVVD short interest.


IVVD Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to IVVD. When comparing the yearly performance of all stocks, IVVD is one of the better performing stocks in the market, outperforming 83.81% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IVVD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to IVVD. IVVD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IVVD Financial Highlights

Over the last trailing twelve months IVVD reported a non-GAAP Earnings per Share(EPS) of -0.97. The EPS increased by 46.41% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -123.55%
ROE -257.38%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%70%
Sales Q2Q%421.5%
EPS 1Y (TTM)46.41%
Revenue 1Y (TTM)1941.08%

IVVD Forecast & Estimates

8 analysts have analysed IVVD and the average price target is 3.06 USD. This implies a price increase of 168.42% is expected in the next year compared to the current price of 1.14.

For the next year, analysts expect an EPS growth of 99.66% and a revenue growth 380.75% for IVVD


Analysts
Analysts82.5
Price Target3.06 (168.42%)
EPS Next Y99.66%
Revenue Next Year380.75%

IVVD Ownership

Ownership
Inst Owners64.85%
Ins Owners13.76%
Short Float %1.8%
Short Ratio0.52